DihydrodaidzeinCAS# 17238-05-0 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 17238-05-0 | SDF | Download SDF |
PubChem ID | 176907 | Appearance | Powder |
Formula | C15H12O4 | M.Wt | 256.26 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Synonyms | 879559-75-8 | ||
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 7-hydroxy-3-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one | ||
SMILES | C1C(C(=O)C2=C(O1)C=C(C=C2)O)C3=CC=C(C=C3)O | ||
Standard InChIKey | JHYXBPPMXZIHKG-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C15H12O4/c16-10-3-1-9(2-4-10)13-8-19-14-7-11(17)5-6-12(14)15(13)18/h1-7,13,16-17H,8H2 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Dihydrodaidzein-producing bacteria might lead to clarification of some of the mechanisms regulating the production of equol by fecal microbiota. |
Targets | P-gp |
In vitro | Dihydrodaidzein-producing Clostridium-like intestinal bacterium, strain TM-40, affects in vitro metabolism of daidzein by fecal microbiota of human male equol producer and non-producers.[Pubmed: 25045313]Biosci Microflora. 2011;30(3):65-71.Much attention has been focused on the biological effects of equol, a metabolite of daidzein produced by intestinal microbiota. However, little is known about the role of isoflavone metabolizing bacteria in the intestinal microbiota. Transport mechanisms for soy isoflavones and microbial metabolites dihydrogenistein and dihydrodaidzein across monolayers and membranes.[Pubmed: 24200780]Biosci Biotechnol Biochem. 2013;77(11):2210-7.Isoflavone data concerning the metabolism and permeability on intestinal epithelial cells are scarce, particularly for microbial isoflavone metabolites. |
Kinase Assay | Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium.[Pubmed: 15640190]Appl Environ Microbiol. 2005 Jan;71(1):214-9.A newly isolated rod-shaped, gram-negative anaerobic bacterium from human feces, named Julong 732, was found to be capable of metabolizing the isoflavone Dihydrodaidzein to S-equol under anaerobic conditions. |
Dihydrodaidzein Dilution Calculator
Dihydrodaidzein Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.9023 mL | 19.5114 mL | 39.0229 mL | 78.0457 mL | 97.5572 mL |
5 mM | 0.7805 mL | 3.9023 mL | 7.8046 mL | 15.6091 mL | 19.5114 mL |
10 mM | 0.3902 mL | 1.9511 mL | 3.9023 mL | 7.8046 mL | 9.7557 mL |
50 mM | 0.078 mL | 0.3902 mL | 0.7805 mL | 1.5609 mL | 1.9511 mL |
100 mM | 0.039 mL | 0.1951 mL | 0.3902 mL | 0.7805 mL | 0.9756 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 2-Hydroxy-3-methoxybenzoic acid glucose ester
Catalog No.:BCN7407
CAS No.:172377-87-6
- Scabioside C
Catalog No.:BCC8358
CAS No.:17233-22-6
- PKC β pseudosubstrate
Catalog No.:BCC5811
CAS No.:172308-76-8
- Mepivacaine HCl
Catalog No.:BCC4796
CAS No.:1722-62-9
- Ilaprazole
Catalog No.:BCC9000
CAS No.:172152-36-2
- Gericudranin E
Catalog No.:BCN8070
CAS No.:172104-07-3
- Alpha-Tocotrienol
Catalog No.:BCN3724
CAS No.:1721-51-3
- H-Phe(4-NO2)-OMe.HCl
Catalog No.:BCC3294
CAS No.:17193-40-7
- SCH 51344
Catalog No.:BCC5613
CAS No.:171927-40-5
- Palmatine chloride monohydrate
Catalog No.:BCC8228
CAS No.:171869-95-7
- Tryprostatin A
Catalog No.:BCN6778
CAS No.:171864-80-5
- 3-O-Coumaroylarjunolic acid
Catalog No.:BCN7131
CAS No.:171864-20-3
- 2-Hydroxy-3-methylanthraquinone
Catalog No.:BCN1108
CAS No.:17241-40-6
- 2-(Hydroxymethyl)anthraquinone
Catalog No.:BCN3090
CAS No.:17241-59-7
- Coumurrayin
Catalog No.:BCN1109
CAS No.:17245-25-9
- 3',4',5',3,5,6,7-Heptamethoxyflavone
Catalog No.:BCN1110
CAS No.:17245-30-6
- 9-Deacetyl-9-benzoyl-10-debenzoyltaxchinin A
Catalog No.:BCN7671
CAS No.:172486-22-5
- Eupatarone
Catalog No.:BCN7199
CAS No.:17249-61-5
- Senkyunolide R
Catalog No.:BCC9144
CAS No.:172549-37-0
- Naringin 4'-glucoside
Catalog No.:BCN8196
CAS No.:17257-21-5
- Murrayamine E
Catalog No.:BCN7908
CAS No.:172617-68-4
- Eucalyptone
Catalog No.:BCN1111
CAS No.:172617-99-1
- Clemastanin A
Catalog No.:BCC8151
CAS No.:172670-47-2
- Fosaprepitant
Catalog No.:BCC4281
CAS No.:172673-20-0
Dihydrodaidzein-producing Clostridium-like intestinal bacterium, strain TM-40, affects in vitro metabolism of daidzein by fecal microbiota of human male equol producer and non-producers.[Pubmed:25045313]
Biosci Microflora. 2011;30(3):65-71.
Much attention has been focused on the biological effects of equol, a metabolite of daidzein produced by intestinal microbiota. However, little is known about the role of isoflavone metabolizing bacteria in the intestinal microbiota. Recently, we isolated a Dihydrodaidzein (DHD)-producing Clostridium-like bacterium, strain TM-40, from human feces. We investigated the effects of strain TM-40 on in vitro daidzein metabolism by human fecal microbiota from a male equol producer and two male equol non-producers. In the fecal suspension from the male equol non-producer and DHD producer, DHD was detected in the in vitro fecal incubation of daidzein after addition of TM-40. The DHD concentration increased as the concentration of strain TM-40 increased. In the fecal suspension from the equol producer, the fecal equol production was increased by the addition of strain TM-40. The occupation ratios of Bifidobacterium and Lactobacillales were higher in the equol non-producers than in the equol producer. Adding isoflavone-metabolizing bacteria to the fecal microbiota should facilitate the estimation of the metabolism of isoflavonoids by fecal microbiota. Studies on the interactions among equol-producing microbiota and DHD-producing bacteria might lead to clarification of some of the mechanisms regulating the production of equol by fecal microbiota.
Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium.[Pubmed:15640190]
Appl Environ Microbiol. 2005 Jan;71(1):214-9.
A newly isolated rod-shaped, gram-negative anaerobic bacterium from human feces, named Julong 732, was found to be capable of metabolizing the isoflavone Dihydrodaidzein to S-equol under anaerobic conditions. The metabolite, equol, was identified by using electron impact ionization mass spectrometry, (1)H and (13)C nuclear magnetic resonance spectroscopy, and UV spectral analyses. However, strain Julong 732 was not able to produce equol from daidzein, and tetrahydrodaidzein and dehydroequol, which are most likely intermediates in the anaerobic metabolism of Dihydrodaidzein, were not detected in bacterial culture medium containing Dihydrodaidzein. Chiral stationary-phase high-performance liquid chromatography eluted only one metabolite, S-equol, which was produced from a bacterial culture containing a racemic mixture of Dihydrodaidzein. Strain Julong 732 did not show racemase activity to transform R-equol to S-equol and vice versa. Its full 16S rRNA gene sequence (1,429 bp) had 92.8% similarity to that of Eggerthella hongkongenis HKU10. This is the first report of a single bacterium capable of converting a racemic mixture of Dihydrodaidzein to enantiomeric pure S-equol.
Transport mechanisms for soy isoflavones and microbial metabolites dihydrogenistein and dihydrodaidzein across monolayers and membranes.[Pubmed:24200780]
Biosci Biotechnol Biochem. 2013;77(11):2210-7.
Isoflavone data concerning the metabolism and permeability on intestinal epithelial cells are scarce, particularly for microbial isoflavone metabolites. This study evaluates the absorption mechanisms for the isoflavones, genistein and daidzein, and their microbial metabolites, dihydrogenistein (DHG) and Dihydrodaidzein (DHD). The permeability characteristics of isoflavones were compared by using the Caco-2 human colon adenocarcinoma cell line for a parallel artificial membrane permeability assay, and comparing their physicochemical properties. The data suggest that genistein, DHG and DHD were efficiently transported by passive diffusion according to the pH-partition hypothesis. Genistein was conjugated by phase II metabolizing enzymes and acted as a substrate of the breast cancer resistance protein (BCRP). Daidzein was not conjugated but did act as a substrate for BCRP, multidrug resistance-associated proteins, and P-glycoprotein. In contrast, DHG and DHD were markedly more permeable than their parent isoflavones; they were therefore difficult to transport by the efflux effect, and glucuronidation/sulfation was limited by the flux time.